RE:RE:RE:RE:Will the Epidiolex exclusivity doors get kicked wide openI know LABS was the first to file their CBD broad spectrum DMF with the FDA. Logically then it is that DMF that would have been referenced by their pharma partner...which imho is what led to the FDA onsite visit/audit and FDA site approval. That CBD broad spectrum DMF is as a unique compound as the hybrid plant from which it came from. Recall LABS clearly stating in the P.R. regarding the DMF...they identified ALL 100 compounds....now that took some very sophisticated lab equipment to "ping" all the molecules, isolate them (again sophisticated lab equipment) and identifiy them (sophisticated lab equipment)....stuff that say a well funded university would have such as McMaster University or a corporate entity such as Pfizer. I wonder if they used a TEM and index of refraction techniques for the molecule identification? The technique is sensitive enough to identify the cubic atomic structure of metals/alloys.